Form 4: Akero Therapeutics CFO William White Sells Shares to Cover Tax Obligations

William Richard White, CFO of Akero Therapeutics, sold 724 shares of common stock on March 13, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 13, 2024, William Richard White, the Chief Financial Officer of Akero Therapeutics, Inc. (AKRO), sold 724 shares of the company's common stock.
• The sale was executed at a price of $28.33 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, White directly owns 49,630 shares of Akero Therapeutics.
• The sale was automatic under the issuer's 'sell-to-cover' policy and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell-to-cover for tax obligations) by a company executive, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a standard 'sell-to-cover' to meet tax obligations, a common practice among executives receiving equity compensation.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates